Based on comprehensive data, we propose the potential implementation of flavonoids as one of the most widely occurring plant-derived substances to target NF-κB-induced cancer cell plasticity, which is related to aberrant signaling associated with crucial cellular mechanisms of BC resistance. This evidence concerns the gene NFKB1 and breast cancer.